Inductive Bio Emerges from Stealth with $4.3M in Funding for Drug Development Acceleration Platform

Inductive Bio, a technology company, has emerged from stealth with $4.3M in funding for its machine learning platform designed to accelerate compound optimization. The platform focuses on optimizing compounds for ADMET properties, co-led by Andreessen Horowitz and Lux Capital.